This issue, focusing on Breast Cancer, includes topics such as: Radiation Therapy for DCIS, Axillary dissection, Pathology in the age of personalized breast cancer treatment:, Clinical implications for breast cancer subsets defined by molecular diagnostics, Management of CNS Metastases in Breast Cancer, Endocrine therapy for advanced breast cancer, Targeting the PI3K pathway in breast cancer, Treating the Older Breast Cancer Patient, Adjuvant chemotherapy in the age of targeted treatment, and Novel radiotherapy approaches for early breast cancer.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Contributors - p. 4 5. Forthcoming Issues - p. 7 6. Preface: Breast Cancer Treatment in the Era of Individualized Care - p. 8 7. Breast Cancer Prevention by Antihormones and Other Drugs - p. 9 8. Radiation Therapy for Duct Carcinoma in Situ - p. 19 9. Management of the Axilla - p. 24 10. Tailoring Adjuvant Treatments for the Individual Patient with Luminal Breast Cancer - p. 30 11. Endocrine Therapy for Advanced/Metastatic Breast Cancer - p. 38 12. The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer - p. 50 13. Treating the HER2 Pathway in Early and Advanced Breast Cancer - p. 56 14. Neoadjuvant Therapy - p. 64 15. Challenges in the Treatment of Older Breast Cancer Patients - p. 71 16. Breast Cancer Survivorship Issues - p. 78 17. What Does Breast Cancer Treatment Cost and What Is It Worth? - p. 92 18. How to Develop and Deliver Pathway-Based Care - p. 101 19. Special Article - p. 104 20. Ibrutinib (PCI-32765) in Chronic Lymphocytic Leukemia - p. 105 21. Index - p. 111
No hay muestra disponible
No hay ficha técnica disponible
This issue, focusing on Breast Cancer, includes topics such as: Radiation Therapy for DCIS, Axillary dissection, Pathology in the age of personalized breast cancer treatment:, Clinical implications for breast cancer subsets defined by molecular diagnostics, Management of CNS Metastases in Breast Cancer, Endocrine therapy for advanced breast cancer, Targeting the PI3K pathway in breast cancer, Treating the Older Breast Cancer Patient, Adjuvant chemotherapy in the age of targeted treatment, and Novel radiotherapy approaches for early breast cancer.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Contributors - p. 4 5. Forthcoming Issues - p. 7 6. Preface: Breast Cancer Treatment in the Era of Individualized Care - p. 8 7. Breast Cancer Prevention by Antihormones and Other Drugs - p. 9 8. Radiation Therapy for Duct Carcinoma in Situ - p. 19 9. Management of the Axilla - p. 24 10. Tailoring Adjuvant Treatments for the Individual Patient with Luminal Breast Cancer - p. 30 11. Endocrine Therapy for Advanced/Metastatic Breast Cancer - p. 38 12. The Management of Early-Stage and Metastatic Triple-Negative Breast Cancer - p. 50 13. Treating the HER2 Pathway in Early and Advanced Breast Cancer - p. 56 14. Neoadjuvant Therapy - p. 64 15. Challenges in the Treatment of Older Breast Cancer Patients - p. 71 16. Breast Cancer Survivorship Issues - p. 78 17. What Does Breast Cancer Treatment Cost and What Is It Worth? - p. 92 18. How to Develop and Deliver Pathway-Based Care - p. 101 19. Special Article - p. 104 20. Ibrutinib (PCI-32765) in Chronic Lymphocytic Leukemia - p. 105 21. Index - p. 111
No hay muestra disponible
No hay ficha técnica disponible
